Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Surprise medical bills cost younger adults more

Millennials are feeling the pain of surprise medical bills more acutely than the generations that preceded them.

UnitedHealthcare UHC UnitedHealth

UnitedHealthcare’s revised CT payment policy ‘threatens’ the patient-physician relationship, advocates warn

The nation’s largest commercial insurer—covering some 70 million Americans—first implemented its imaging reimbursement update in the spring, drawing concern from the field. 

Thumbnail

CMS’ move to reimburse doctors for imaging algorithm use is encouraging. But is it enough?

Some are calling on the agency to boost proposed payments for a tool that diagnoses diabetic retinopathy in order to encourage widespread adoption.

Thumbnail

Envision inks in-network radiology deal with Humana, Akumin’s Q3 earnings, plus more company news

Also, Irish teleradiology leader sells for almost $19 million, SimonMed's latest partnership, and New Jersey practice changes its name. 

insurance payer payment insurer

Top nuclear imaging group ‘strongly disagrees’ with Humana’s decision to refuse coverage for PET/CT

The Society of Nuclear Medicine and Molecular Imaging said the move denies patients access to potentially lifesaving technologies.

COVID-19 congress coronavirus Washington

Radiology among 74 medical groups pressing politicians to protect providers from ‘devastating’ pay cuts

ACR, SNMMI and others voiced their support this week for the “Holding Providers Harmless from Medicare Cuts During COVID-19 Act."

Thumbnail

Delaware cardiology practice to pay $500K to resolve fraud allegations

The alleged wrongdoings, reported by a whistleblower, occurred from April 2014 to March 2020.

Life sciences going all in with AI, with many companies spending upwards of $50M—and counting

The COVID crisis will spur leaders of life sciences companies around the world to focus on longstanding pain points that AI could help alleviate. And the execs are looking to put their money where their responses are.